ESCITALOPRAM | ESCITALOPRAM : Inhibitor of SLC6A4
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (2 reviews)
Control Compounds

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
SLC6A4
  • Kd:2.1 nM
  • Ki:0.89 nM
  • Activity:89-3% residual activity
less than 1 µM
up to 10 uM

Selectivity

In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET): Ki = 10500 nM ...

Potency
Cellular
In Vitro

SLC6A4

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1038/nature17629

In Vivo Validations

Rat
Dose: 1.6 mg/Kg
Route of delivery: Subcutaneous
Plasma half life: 54 min
Cmax: 131 nM
Tmax: 26 min
Area Under the Curve:: 13,888 nM*min
Fb : 50%

DOI Reference: 10.1124/dmd.112.045682

Chemical Information

Molecular Formula C20H21FN2O
SMILEs CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
InChI InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1
Molecular weight 324.16 Da
AlogP 3.812980000000003
HBond acceptors 3
HBond donors --
Atoms 45

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the Portal.

Expert Reviews


(on 18 Jan 2023)
Cellular Use Rating
In Model Organisms
Escitalopram is a highly potent and selective SERT inhibitor drug. It is also a relatively lipophilic basic compound. High concentrations should not be required to probe SERT biology and may lead to polypharmacological...
(on 2 Feb 2023)
Cellular Use Rating
In Model Organisms
Escitalopram, the active (S)-enantiomer of citalopram, has been approved for the treatment of depression and anxiety disorders for many years. It is more potent and selective than the racemate citalopram...
If you wish to explore AI-generated evaluations, please visit the page on our collaborator Compound VALET.
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria